VAERS reports by lot

GSK Flu lot 2MA5F: VAERS reports

23 VAERS reports list lot 2MA5F as a GSK Flu vaccine, received between 2018-09-07 and 2019-03-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
9%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1823%
General / Systemic (non-local)1519%
Neurological1215%
Musculoskeletal912%
Allergic / Anaphylactic68%
Respiratory56%
Cardiac / Cardiovascular45%
Gastrointestinal45%
Dermatological (non-injection-site)45%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
Georgia3
Massachusetts2
West Virginia2
Illinois2
Pennsylvania2
District of Columbia1
North Carolina1
Missouri1
Utah1
Delaware1
Colorado1

Reports by month received

2018-095
2018-1011
2018-114
2018-121
2019-021
2019-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.